PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

NCT02814968 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: Enzalutamide
DEVICE: 18-FDG PET/CT
DEVICE: Whole body MRI
DEVICE: Bone scan

Sponsor

The European Uro-Oncology Group

Collaborators

[object Object]